Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neurofeedback as a Novel Treatment for Mild Cognitive Impairment & Early Alzheimer's

NCT02987842 is registered in ClinicalTrials.gov with Beersheva Mental Health Center as lead sponsor.

NCT NCT02987842
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02987842 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neurofeedback as a Novel Treatment for Mild Cognitive Impairment & Early Alzheimer's
Lead sponsor
Beersheva Mental Health Center
Phase
Not applicable
Overall status
Unknown status
Start date
December 31, 2016
Completion date
December 31, 2017
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, mild cognitive impairment